ProPhase Labs (PRPH) Payables (2010 - 2026)
ProPhase Labs (PRPH) reported Payables of $32.75 million for Q2 2026, up 83.5% from $17.85 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
ProPhase Labs (PRPH) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, ProPhase Labs posted Payables of $32.61 million, up 92.7% from FY2024.
- Payables has increased for three consecutive years, with a five-year compound annual growth rate of 54.0% (FY2020 to FY2025).
- By year, Payables came in at $16.92 million in FY2024 (+95.8%), $8.64 million in FY2023 (+46.4%), $5.91 million in FY2022 (-16.0%) and $7.03 million in FY2021 (+86.3%).
- The Q2 2026 figure ranks as the highest quarterly Payables in data going back to Q4 2010.
- Year over year, Payables has now increased in each of the last 13 quarters, with growth averaging 87.6% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q3 2023 (growth of 253.9%); the low point was Q1 2023 (a decline of 40.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $32.71 million (Q1 2026), $32.61 million (Q4 2025) and $31.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 7.03 Bn |
| 10 | ProPhase Labs | 120,537.60 | -425,462.40 | 226,000.00 | 32.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.75 Mn |
| Mar 31, 2026 | 32.71 Mn |
| Dec 31, 2025 | 32.61 Mn |
| Sep 30, 2025 | 31.32 Mn |
| Jun 30, 2025 | 17.85 Mn |
| Mar 31, 2025 | 15.78 Mn |
| Dec 31, 2024 | 16.92 Mn |
| Sep 30, 2024 | 18.13 Mn |
| Jun 30, 2024 | 16.89 Mn |
| Mar 31, 2024 | 14.14 Mn |
| Dec 31, 2023 | 8.64 Mn |
| Sep 30, 2023 | 5.47 Mn |
| Jun 30, 2023 | 4.79 Mn |
| Mar 31, 2023 | 4.87 Mn |
| Dec 31, 2022 | 5.91 Mn |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | 4.45 Mn |
| Mar 31, 2022 | 8.20 Mn |
| Dec 31, 2021 | 7.03 Mn |
| Sep 30, 2021 | 2.39 Mn |
API Access
ProPhase Labs Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PRPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PRPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PRPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();